Maximum residue levels for captan, propiconazole and spiroxamine in or on certain products

The proposal notified in G/SPS/N/EU/142 (9 July 2015) is now adopted as Commission Regulation (EU) 2016/452 of 29 March 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for captan, propiconazole and spiroxamine in or on certain products (Text with EEA relevance) [OJ L 79, 30 March 2016, pp. 10-27].
Draft MRLS for boscalid, clothianidin, thiametoxam, folpet and tolclofos-methyl were notified in G/SPS/N/EU/142 and have been published in Commission Regulation (EU) 2016/156 of 18 January 2016.
The European Union received a comment from one of its trading partners with regard to captan and therefore this substance was voted at a later stage and the MRL for captan was published in Commission Regulation (EU) 2016/452 that is hereby notified.
Draft MRLS for propiconazole and spiroxamine were originally notified in G/SPS/N/EU/136/Add.1 (25 September 2015) and have been published in Regulation 2016/452 that is hereby notified.
Commission Regulation (EU) 2016/452 applies from 19 October 2016.
http://members.wto.org/crnattachments/2016/SPS/EEC/16_1613_00_e.pdf
http://members.wto.org/crnattachments/2016/SPS/EEC/16_1613_00_f.pdf
http://members.wto.org/crnattachments/2016/SPS/EEC/16_1613_00_s.pdf